Aim. To determine the efficacy and safety of vitamin D3 supplementation in reducing depressive symptoms in women with type 2 diabetes (T2D), depression, and low vitamin D. Methods. In this double-blind randomized active comparator-controlled trial, women with significant depressive symptoms as assessed by the Center for Epidemiologic Studies Depression (CES-D) scale received weekly oral vitamin D3 supplementation (50,000 IU) or an active comparator (5,000 IU) for 6 months. Assessments of vitamin D, 25-hydroxyvitamin D [25 (OH) D], and depression were measured at baseline, 3 months, and 6 months. Results. A total of 129 women were randomized, from which 119 completed the study (57 in lower dose and 62 in higher dose). Participants had an average 25 (OH) D and HbA1c of 20.8 ng/mL and 7.8%, respectively, at baseline. They were diverse (48% Black) and had a mean age of 50 and T2D for about 8 years. Upon completion of vitamin D3 supplementation, serum 25 (OH) D levels increased with 50,000 IU (+34 ng/mL) and 5,000 IU (+10 ng/mL). There was no difference in CES-D scores by treatment dose. Overall, depressive symptoms significantly improved over time with an average CES-D decline of 12.98 points (95% CI: −15.04 to −10.93; ). Among women with moderate baseline depressive symptoms, those receiving the lower dose had nominally lower depression scores at follow-up than those in the higher dose cohort. Among women with severe baseline depressive symptoms, the improvement in follow-up depression scores was the same regardless of dose. Conclusions. There was no difference in the dosing effect of vitamin D3 supplementation for the treatment of depressive symptoms in women with T2D who present with significant symptoms and low vitamin D. Regardless of the dose, participants’ mood improved over time. Further study of vitamin D to target depressive symptoms in comorbid populations is needed.
The purpose of this study was to explore factors associated with inner strength in women following coronary stent placement. A grounded theory design using the "middle range theory of inner strength in women" guided the study. The research question was "How do women experience inner strength during their recovery from coronary stent placement following an acute coronary event?" A sample of 12 women with history of post-myocardial infarction cardiac stent placement completed semistructured interviews. Categories of data emerged to include "changing patterns of fear" and stages of "living a new normal." Data analysis resulted in themes consistent with previous research of inner strength in women. The results provide a theory-based foundation for critical care practice interventions to promote the health of women experiencing a life-threatening infarction and a stent placement. Nursing interventions extending into rehabilitation can enhance the quality of life in women living with coronary artery disease as a chronic condition.
17 October 2022 in Child: Care, Health and Development
Aim: The purpose of this study was to examine the trajectories of condition and independent living self‐management in youth with spina bifida (SB).Methods: A diverse sample of adolescents and young adults (AYAs) with SB completed the Adolescent/Young Adult Self‐Management and Independence Scale (AMIS‐II) across four time points. Parents reported on demographic characteristics including age, sex, race/ethnicity, and family income. Growth in self‐management and its subscales (condition and independent living) were estimated using linear mixed‐effect models as a function of respondents' demographics.Results: This study included 99 respondents age 18 to 27 years old. About half were female (52.5%) and White (52.5%); 15.2% were Black, and about a third were Hispanic/Latino (32.3%). Eighty‐seven AYAs (87.9%) had myelomeningocele. The lesion level was 31.3% sacral, 48.5% lumbar and 18.2% thoracic. A third of the families earned less than 50K. Overall, self‐management growth was dependent on age, sex, and race/ethnicity, but not income. Growth in condition self‐management depended on sex; only males demonstrated increasing growth ( = 0.11, p < 0.001). Black participants endorsed higher increasing total and condition self‐management when compared with White ( diff = 0.17 and 0.17, respectively, both p < 0.05) and Hispanic/Latino ( diff = 0.18 and 0.21, respectively, both p = 0.02) respondents.Conclusion: This study provides evidence of differences in growth of self‐management by demographic/social determinants of health. Possible reasons for differences are discussed. Predictors of changes in self‐management behaviours over time in young adults with SB can identify subgroups in need of further study.
30 November 2016 in Journal of Pediatric Rehabilitation Medicine
PURPOSE: The purpose of this study was to explore factors related to parental depressive symptoms (PDS) and family quality of life (FQOL) in parents of adolescents and young adults (AYA) with and without a specific chronic health condition (CHC), spi